NCT02855281View on ClinicalTrials.gov

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Lung Neoplasms
Trial Locations (1)

42699

Wissenschaftliches Institut Bethanien e. V., Solingen

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

lead

Wissenschaftliches Institut Bethanien e.V

OTHER

NCT02855281 - Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter